Reducing agent-mediated precipitation of high-abundance plasma proteins

Analytical Biochemistry

Volumn 387, Issue 2, 2009, Pages 184-193

  Warder, Scott E ^a   Tucker, Lora A ^a   Strelitzer, Tamara J ^a   McKeegan, Evelyn M ^a   Meuth, Joseph L ^a   Jung, Paul M ^a   Saraf, Anita ^a   Singh, Bhawani ^b   Lai Zhang, Jie ^a   Gagne, Gerard ^a   Rogers, John C ^a  

^a ABBOTT LABORATORIES   (United States)

^b Abbott Molecular Inc   (United States)

Author keywords

Albumin; Depletion; MALDI TOF MS; Quantification; Reducing agents

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; INDUCTIVELY COUPLED PLASMA; PHOSPHORUS COMPOUNDS; PROTEINS; SULFUR COMPOUNDS;

ALBUMIN; DEPLETION; HIGH-ABUNDANCE PROTEINS; MALDI TOF MS; PROTEOMIC ANALYSIS; QUANTIFICATION; SAMPLE PREPARATION; TRIS(2-CARBOXYETHYL) PHOSPHINE;

REDUCING AGENTS;

ALBUMIN; ANGIOGENESIS INHIBITOR; BIOLOGICAL MARKER; DISULFIDE; DITHIOTHREITOL; NITROGEN 15; PLASMA PROTEIN; PLASMINOGEN; RECOMBINANT KRINGLE 5; REDUCING AGENT; SINAPIC ACID; THROMBOCYTE FACTOR 4; TRANSFERRIN; TRIS(2 CARBOXYETHYL)PHOSPHINE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; COW; DOG; DRUG BLOOD LEVEL; FLUORESCENCE MICROSCOPY; GROUPS BY AGE; HUMAN; IONIZATION; KRINGLE DOMAIN; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONKEY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; RAT; REDUCING AGENT MEDIATED PRECIPITATION; REDUCING AGENT MEDIATED SIGNAL ENHANCEMENT; REPRODUCIBILITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TEMPERATURE SENSITIVITY; WESTERN BLOTTING;

EID: 61849134438     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.01.013     Document Type: Article

References (53)

1. Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1 (2002) 845-867
2. Bailey J., Zhang K., Zolotarjova N., Nicol G., and Szafranski C. Removing high-abundance proteins from serum. Genet. Eng. News 23 (2003) 32-36
3. Gianazza E., and Arnaud P. Chromatography of plasma proteins on immobilized cibacron blue F3-GA. Mechanism of the molecular interaction. Biochem. J. 203 (1982) 637-641
4. Thompson S.T., Cass K.H., and Stellwagen E. Blue dextran-sepharose: an affinity column for the dinucleotide fold in proteins. Proc. Natl. Acad. Sci. USA 72 (1975) 669-672
5. Greenough C., Jenkins R.E., Kitteringham N.R., Pirmohamed M., Park B.K., and Pennington S.R. A method for the rapid depletion of albumin and immunoglobulin from human plasma. Proteomics 4 (2004) 3107-3111
6. Pieper R., Gatlin C.L., Makusky A.J., Russo P.S., Schatz C.R., Miller S.S., Su Q., McGrath A.M., Estock M.A., Parmar P.P., Zhao M., Huang S.T., Zhou J., Wang F., Esquer-Blasco R., Anderson N.L., Taylor J., and Steiner S. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3 (2003) 1345-1364
7. Steel L.F., Trotter M.G., Nakajima P.B., Mattu T.S., Gonye G., and Block T. Efficient and specific removal of albumin from human serum samples. Mol. Cell. Proteomics 2 (2003) 262-270
8. Wang Y.Y., Cheng P., and Chan D.W. A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis. Proteomics 3 (2003) 243-248
9. Hoffman S.A., Joo W.A., Echan L.A., and Speicher D.W. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma. J. Chromatogr. B 849 (2007) 43-52
10. Huang L., Harvie G., Feitelson J.S., Gramatikoff K., Herold D.A., Allen D.L., Amunngama R., Hagler R.A., Pisano M.R., Zhang W.W., and Fang X. Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis. Proteomics 5 (2005) 3314-3328
11. Guerrier L., Thulasiraman V., Castagna A., Fortis F., Lin S., Lomas L., Righetti P.G., and Boschetti E. Reducing protein concentration range of biological samples using solid-phase ligand libraries. J. Chromatogr. B 833 (2006) 33-40
12. Jiang L., He L., and Fountoulakis M. Comparison of protein precipitation methods for sample preparation prior to proteomic analysis. J. Chromatogr. A 1023 (2004) 317-320
13. Gretzer M.B., Chan D.W., van Rootselaar C.L., Rosenzweig J.M., Dalrymple S., Mangold L.A., Partin A.W., and Veltri R.W. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF. Prostate 60 (2004) 325-331
14. Chan R., Chen V., and Bucknall M.P. Quantitative analysis of membrane fouling by protein mixtures using MALDI-MS. Biotechnol. Bioeng. 85 (2004) 190-201
15. Velasco C., Ouammou M., Calvo J.I., and Hernandez A. Protein fouling in microfiltration: deposition mechanism as a function of pressure for different pH. J. Colloid Interface Sci. 266 (2003) 148-152
16. Colantonio D.A., Dunkinson C., Bovenkamp D.E., and Van Eyk J.E. Effective removal of albumin from serum. Proteomics 5 (2005) 3831-3835
17. Wasinger V.C., Locke V.L., Raftery M.J., Larance M., Rothemund D., Liew A., Bate I., and Guilhaus M. Two-dimensional liquid chromatography/tandem mass spectrometry analysis of Gradiflow fractionated native human plasma. Proteomics 5 (2005) 3397-3401
18. Adkins J.N., Varnum S.M., Auberry K.J., Moore R.J., Angell N.H., Smith R.D., Springer D.L., and Pounds J.G. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics 1 (2002) 947-955
19. Shen Y., Jacobs J.M., Camp II D.G., Fang R., Moore R.J., Smith R.D., Xiao W., Davis R.W., and Tompkins R.G. Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal. Chem. 76 (2004) 1134-1144
20. W.J. Qian, M.E. Monroe, T. Liu, J.M. Jacobs, G.A. Anderson, Y. Shen, R.J. Moore, D.J. Anderson, R. Zhang, S.E. Calvano, S.F. Lowry, W. Xiao, L.L. Moldawer, R.W. Davis, R.G. Tompkins, D.G. Camp, 2nd, R.D. Smith, Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol. Cell. Proteomics (2005).
21. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., Mills G.B., Simone C., Fishman D.A., Kohn E.C., and Liotta L.A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
22. Adam B.L., Qu Y., Davis J.W., Ward M.D., Clements M.A., Cazares L.H., Semmes O.J., Schellhammer P.F., Yasui Y., Feng Z., and Wright Jr. G.L. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62 (2002) 3609-3614
23. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., and Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48 (2002) 1296-1304
24. Mehta A.I., Ross S., Lowenthal M.S., Fusaro V., Fishman D.A., Petricoin III E.F., and Liotta L.A. Biomarker amplification by serum carrier protein binding. Dis. Markers 19 (2003) 1-10
25. Zhou M., Lucas D.A., Chan K.C., Issaq H.J., Petricoin III E.F., Liotta L.A., Veenstra T.D., and Conrads T.P. An investigation into the human serum "interactome". Electrophoresis 25 (2004) 1289-1298
26. Diamandis E.P. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps. Cancer Res. 66 (2006) 5540-5541
27. Hortin G.L. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin. Chem. 52 (2006) 1223-1237
28. Hortin G.L., Sviridov D., and Anderson N.L. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 54 (2008) 1608-1616
29. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
30. Washburn M.P., Wolters D., and Yates III J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19 (2001) 242-247
31. Link A.J., Eng J., Schieltz D.M., Carmack E., Mize G.J., Morris D.R., Garvik B.M., and Yates III J.R. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17 (1999) 676-682
32. Yates III J.R., Carmack E., Hays L., Link A.J., and Eng J.K. Automated protein identification using microcolumn liquid chromatography-tandem mass spectrometry. Methods Mol. Biol. 112 (1999) 553-569
33. Tabb D.L., McDonald W.H., and Yates III J.R. DTASelect and contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1 (2002) 21-26
34. Domon B., and Aebersold R. Mass spectrometry and protein analysis. Science 312 (2006) 212-217
35. Cao Y., Chen A., An S.S., Ji R.W., Davidson D., and Llinas M. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272 (1997) 22924-22928
36. Cao Y., Ji R.W., Davidson D., Schaller J., Marti D., Sohndel S., McCance S.G., O'Reilly M.S., Llinas M., and Folkman J. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271 (1996) 29461-29467
37. Davidson D.J., Haskell C., Majest S., Kherzai A., Egan D.A., Walter K.A., Schneider A., Gubbins E.F., Solomon L., Chen Z., Lesniewski R., and Henkin J. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res. 65 (2005) 4663-4672
38. Gonzalez-Gronow M., Kaczowka S.J., Payne S., Wang F., Gawdi G., and Pizzo S.V. Plasminogen structural domains exhibit different functions when associated with cell surface GRP78 or the voltage-dependent anion channel. J. Biol. Chem. 282 (2007) 32811-32820
39. Gonzalez-Gronow M., Kalfa T., Johnson C.E., Gawdi G., and Pizzo S.V. The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells. J. Biol. Chem. 278 (2003) 27312-27318
40. Dati F., Schumann G., Thomas L., Aguzzi F., Baudner S., Bienvenu J., Blaabjerg O., Blirup-Jensen S., Carlstrom A., Petersen P.H., Johnson A.M., Milford-Ward A., Ritchie R.F., Svendsen P.J., and Whicher J. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur. J. Clin. Chem. Clin. Biochem. 34 (1996) 517-520
41. Ueki T., Hiragi Y., Kataoka M., Inoko Y., Amemiya Y., Izumi Y., Tagawa H., and Muroga Y. Aggregation of bovine serum albumin upon cleavage of its disulfide bonds, studied by the time-resolved small-angle X-ray scattering technique with synchrotron radiation. Biophys. Chem. 23 (1985) 115-124
42. Sawyer J.T., Lukaczyk T., and Yilla M. Dithiothreitol treatment induces heterotypic aggregation of newly synthesized secretory proteins in HepG2 cells. J. Biol. Chem. 269 (1994) 22440-22445
43. Ji Q.C., Rodila R., Gage E.M., and El-Shourbagy T.A. A strategy of plasma protein quantitation by selective reaction monitoring of an intact protein. Anal. Chem. 75 (2003) 7008-7014
44. Desiderio D.M., Wirth U., Lovelace J.L., Fridland G., Umstot E.S., Nguyen T.M., Schiller P.W., Szeto H.S., and Clapp J.F. Matrix-assisted laser desorption/ionization mass spectrometric quantification of the mu opioid receptor agonist DAMGO in ovine plasma. J. Mass Spectrom. 35 (2000) 725-733
45. Kaplan K.L., and Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57 (1981) 199-202
46. Sarode R., Bhasin D., Marwaha N., Roy P., Singh K., Panigrahi D., Garewal G., and Mehta S.K. Hyperaggregation of platelets in intestinal tuberculosis: role of platelets in chronic inflammation. Am. J. Hematol. 48 (1995) 52-54
47. Zahavi J., Jones N.A., Leyton J., Dubiel M., and Kakkar V.V. Enhanced in vivo platelet "release reaction" in old healthy individuals. Thromb. Res. 17 (1980) 329-336
48. Lam Y.W., Mobley J.A., Evans J.E., Carmody J.F., and Ho S.M. Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer. Proteomics 5 (2005) 2927-2938
49. Cho W.C., Yip T.T., Ngan R.K., Yip T.T., Podust V.N., Yip C., Yiu H.H., Yip V., Cheng W.W., Ma V.W., and Law S.C. ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin. Chem. 53 (2007) 241-250
50. Al-Mondhiry H. Beta-thromboglobulin and platelet-factor 4 in patients with cancer: correlation with the stage of disease and the effect of chemotherapy. Am. J. Hematol. 14 (1983) 105-111
51. Meuwis M.A., Fillet M., Geurts P., de Seny D., Lutteri L., Chapelle J.P., Bours V., Wehenkel L., Belaiche J., Malaise M., Louis E., and Merville M.P. Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem. Pharmacol. 73 (2007) 1422-1433
52. Vermeulen R., Lan Q., Zhang L., Gunn L., McCarthy D., Woodbury R.L., McGuire M., Podust V.N., Li G., Chatterjee N., Mu R., Yin S., Rothman N., and Smith M.T. Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc. Natl. Acad. Sci. USA 102 (2005) 17041-17046
53. Aivado M., Spentzos D., Germing U., Alterovitz G., Meng X.Y., Grall F., Giagounidis A.A., Klement G., Steidl U., Otu H.H., Czibere A., Prall W.C., Iking-Konert C., Shayne M., Ramoni M.F., Gattermann N., Haas R., Mitsiades C.S., Fung E.T., and Libermann T.A. Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc. Natl. Acad. Sci. USA 104 (2007) 1307-1312